The Uromigos Episode 66: Paper of the Month—Two Papers in Nature Medicine on Neoadjuvant Immune Combinations in Bladder Cancer

Dr. Pam Sharma and Dr. Michiel Van Der Heijden discuss their respective papers published in Nature Medicine on neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer.

Related Episodes

Episode 189: The Uromigos Paper of the Month—Robotic Versus Open Cystectomy
Episode 187: Cora Sternberg – The Uromigos Legends Series
The Uromigos Episode 169: Paper of the Month—Novel Neoadjuvant Approaches in UC
The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data
The Uromigos Episode 164: Paper of the Month—What Can We Learn from R3 Ipilimumab/Nivolumab in Gastric Cancer
The Uromigos Episode 162: Debate—Adjuvant Nivolumab for Bladder Cancer
The Uromigos Episode 161: Platinum Ineligibility in Urothelial Cancer
The Uromigos Episode 156: ASCO GU 2022 First-Line Olaparib and Durvalumab in Bladder Cancer
The Uromigos Episode 152: Paper of the Month—Zr-Pembrolizumab PET Imaging
The Uromigos Episode 151: Bladder Cancer ESMO Guidelines Update